SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

LQDA

Liquidia Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001104659-26-048610
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no contentious shareholder proposals. Monitor for any unexpected changes in director nominations or auditor ratification in future filings, but no immediate action is required.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
LQDA ▲ +133.10% at T+60d
NEUTRAL call +133.10% · α vs SPY +128.32% · entry $37.34 → $87.04
Entry = T+0 close
Apr 24, 2026
via day close
T+1d
+0.83%
call +0.83% · α +1.32%
$37.65
settled 6mo ago
T+5d
+3.05%
call +3.05% · α +2.65%
$38.48
settled 6mo ago
T+20d
+60.94%
call +60.94% · α +55.98%
$60.10
settled 5mo ago
T+60d
+133.10%
call +133.10% · α +128.32%
$87.04
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Liquidia Corp (LQDA) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Stockholders Meeting, scheduled for June 16, 2026. The meeting will be held virtually, and shareholders are asked to vote on the election of three directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and the approval of executive compensation. The Board of Directors recommends voting FOR all proposals.

Key Financial Metrics

Vote
director election
Meeting
2026-06-16

Key Facts

  • Annual meeting scheduled for June 16, 2026, to be held virtually.
  • Three director nominees: David Johnson, Katie Rielly-Gauvin, and Ramandeep Singh.
  • Proposal to ratify PricewaterhouseCoopers LLP as the independent auditor.
  • Proposal to approve, on an advisory basis, the compensation of named executive officers.
  • Board of Directors recommends voting FOR all nominees and proposals.

Financial Impact

No direct financial impact from the proxy statement itself.

governanceexecutive_compensation

Risk Factors

  • Routine annual meeting with no significant governance risks indicated.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-048610
Document: 0001104659-26-048610-index-headers.html0001104659-26-048610
Document: 0001104659-26-048610-index.html0001104659-26-048610
Document: 0001104659-26-048610.txt0001104659-26-048610
45 reports for LQDA
Performance horizon
57% Hit rate @ T+1 12 of 21 directional calls Went positive at some point 15 of 21 best @ T+60▲ +70.18%Mar 5, 2026
Filters
Rows
Reports for LQDA — sortable, filterable
TypeNow
Oct 13, 2026
12d ago
8-K
MIXED ★ 7/10
$33.94 $34.78▲ +2.48%▲ +2.19%$43.74 (+28.87%)
Oct 13, 2026
12d ago
Insider Cluster
NEUTRAL ★ 4/10
$33.94 $34.78▲ +2.48%▲ +2.19%$43.74 (+28.87%)
Sep 30, 2026
25d ago
8-K
BEARISH ★ 7/10
$27.99 $28.64▼ −2.32%▼ −1.58%$43.74 (−56.27%)
Sep 3, 2026
7w ago
8-K
BULLISH ★ 5/10
$68.63 $68.66▲ +0.04%▲ +0.43%$43.74 (−36.27%)
Sep 3, 2026
7w ago
Press Release
BULLISH ★ 6/10
$68.63 $68.66▲ +0.04%▲ +0.43%$43.74 (−36.27%)
Aug 25, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$71.36 $69.94▼ −1.99%▼ −2.65%$43.74 (−38.71%)
Aug 21, 2026
9w ago
Insider Cluster
NEUTRAL ★ 4/10
$70.27 $70.49▲ +0.31%▼ −0.01%$43.74 (−37.75%)
Aug 12, 2026
10w ago
8-K
BULLISH ★ 6/10
$78.79 $72.10▼ −8.49%▼ −9.19%$43.74 (−44.49%)
Aug 12, 2026
10w ago
Press Release
BEARISH ★ 6/10
$78.79 $72.10▲ +8.49%▲ +9.19%$43.74 (+44.49%)
Jul 29, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$86.80 $84.11▼ −3.10%▼ −3.82%$43.74 (−49.61%)
Showing 10 of 45

US Market Status

Market Closed — Opens Tue (16h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026